Pentadecanoic Triglyceride Composition for Retinal ER Stress Protection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a lack of effective orally ingestible compositions that can ameliorate ocular tissue disorders caused by endoplasmic reticulum stress due to light stimuli, such as blue light, and prevent or treat visual field defect disorders like glaucoma, with existing substances like hesperidin and lactic acid bacteria not providing sufficient efficacy.
Innovation Solution
Triglycerides composed mainly of saturated fatty acids, particularly pentadecanoic acid, are used to inhibit denatured protein accumulation and reduce cell death in the endoplasmic reticulum, thereby preventing and treating ocular tissue disorders and visual field defects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing substances like hesperidin and lactic acid bacteria are used, then some protective effect against ocular tissue disorders is achieved, but the efficacy is not sufficient to effectively prevent or treat visual field defect disorders and glaucoma
Solution Approach 1:
The patent changes the chemical parameter of the active ingredient from conventional substances (hesperidin, lactic acid bacteria) to a specific chemical compound (N-acetylcarnosine) with defined molecular structure and properties, achieving superior efficacy in preventing and treating ocular tissue disorders caused by endoplasmic reticulum stress
Solution Approach 2:
The patent extracts and isolates the specific active ingredient N-acetylcarnosine from complex natural sources, creating a purified composition that targets endoplasmic reticulum stress mechanisms directly, thereby achieving reliable therapeutic effects without the complexity of whole-cell or crude extract formulations
2Measurement precision
If blue LED light irradiation is used for treatment or detection, then visual function assessment is enabled, but endoplasmic reticulum stress is induced causing photoreceptor cell death
Solution Approach 1:
The patent applies N-acetylcarnosine as a preventive agent before light exposure occurs, establishing protective mechanisms against endoplasmic reticulum stress in advance. This preliminary protection prevents the harmful effects of blue light irradiation while allowing the light to be used for visual function assessment
Solution Approach 2:
The patent converts the harmful effect of blue light (inducing endoplasmic reticulum stress) into a beneficial diagnostic tool by using controlled light irradiation for visual field assessment, while simultaneously applying N-acetylcarnosine to prevent the harmful cellular responses, thus transforming a potentially damaging exposure into a safe and useful diagnostic procedure
Data Source
AI summary
Provided is a composition for visual field defect disorders, glaucoma, light-induced ocular tissue damage and related disorders, which can be used as a food or drug for long-term administration, prevention, symptom relief and improvement. A composition comprising a triglyceride represented by the formula (I):(wherein R1, R2, and R3 are each a saturated fatty acid residue, and at least one of them is a pentadecanoic acid residue) as an active ingredient.